American College of Physicians, Philadelphia, Pennsylvania (A.Q., I.E.).
University of Kansas Medical Center, Kansas City, Kansas (R.A.M.).
Ann Intern Med. 2021 Jul;174(7):985-993. doi: 10.7326/M20-7844. Epub 2021 Apr 27.
The American College of Physicians (ACP) developed this guideline to provide clinical recommendations on the appropriate use of point-of-care ultrasonography (POCUS) in patients with acute dyspnea in emergency department (ED) or inpatient settings to improve the diagnostic, treatment, and health outcomes of those with suspected congestive heart failure, pneumonia, pulmonary embolism, pleural effusion, or pneumothorax.
The ACP Clinical Guidelines Committee based this guideline on a systematic review on the benefits, harms, and diagnostic test accuracy of POCUS; patient values and preferences; and costs of POCUS. The systematic review evaluated health outcomes, diagnostic timeliness, treatment decisions, and test accuracy. The critical health, diagnostic, and treatment outcomes evaluated were in-hospital mortality, time to diagnosis, and time to treatment. The important outcomes evaluated were intensive care unit admissions, correctness of diagnosis, disease-specific outcomes, hospital readmissions, length of hospital stay, and quality of life. The critical test accuracy outcomes included false-positive results for suspected pneumonia, pneumothorax, and pulmonary embolism and false-negative results for suspected congestive heart failure, pneumonia, pneumothorax, and pulmonary embolism. Important test accuracy outcomes included false-positive results for suspected congestive heart failure and false-negative and false-positive results for suspected pleural effusion. This guideline was developed using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) method.
The target audience is all clinicians, and the target patient population is adult patients with acute dyspnea in ED or inpatient settings.
美国医师学院(ACP)制定了本指南,为急诊科(ED)或住院环境中急性呼吸困难患者使用即时护理超声(POCUS)提供临床建议,以改善疑似充血性心力衰竭、肺炎、肺栓塞、胸腔积液或气胸患者的诊断、治疗和健康结局。
ACP 临床指南委员会基于 POCUS 的益处、危害和诊断测试准确性、患者价值观和偏好以及 POCUS 的成本的系统评价制定了本指南。系统评价评估了健康结局、诊断及时性、治疗决策和测试准确性。评估的关键健康、诊断和治疗结局包括院内死亡率、诊断时间和治疗时间。评估的重要结局包括重症监护病房入院、诊断正确性、特定疾病结局、医院再入院、住院时间和生活质量。评估的重要测试准确性结局包括疑似肺炎、气胸和肺栓塞的假阳性结果以及疑似充血性心力衰竭、肺炎、气胸和肺栓塞的假阴性结果。重要的测试准确性结果包括疑似充血性心力衰竭的假阳性结果以及疑似胸腔积液的假阴性和假阳性结果。本指南使用 GRADE(推荐评估、制定和评价)方法制定。
目标受众是所有临床医生,目标患者人群是 ED 或住院环境中急性呼吸困难的成年患者。